Scientists at La Jolla Institute for Immunology (LJI) have published the first analysis of how four types of COVID-19 vaccines prepare the body to fight SARS-CoV-2. Their in-depth look at how T cells, B cells, antibody levels ...
May 31, 2022
1
148
A new study shows that it is possible to use the genetic sequences of a person's antibodies to predict what pathogens those antibodies will target. Reported in the journal Immunity, the new approach successfully differentiates ...
Apr 21, 2022
0
5
SARS-CoV-2, the virus that causes COVID-19, has continuously mutated since it emerged in late 2019. This rapid evolution poses challenges for vaccines and treatments designed to target the virus. A booster shot is now needed ...
Apr 16, 2022
0
4
Immunotherapies for cancer rely on recruiting the patient's immune system, but they still fall far short of tapping into the entire arsenal of the body's natural defenses. In fact, most such therapies draw on one type of ...
Mar 23, 2022
0
77
At the beginning of the COVID pandemic, we were hopeful that pre-existing immunity to the common cold could protect you from COVID, but new evidence suggests that sometimes the opposite can happen. A new University of Rochester ...
Mar 7, 2022
0
147
One of the major successes of decades of cancer research has been the development of drugs that specifically inactivate oncogenes, genes that function abnormally, causing cells to behave erratically, become malignant and ...
Mar 1, 2022
0
59
T-cell responses directed against the receptor-binding domain of the SARS-CoV-2 spike protein were associated with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer, with lower T-cell responses ...
Feb 18, 2022
0
23
(HealthDay)—For patients undergoing hemodialysis, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA-1273 vaccine elicits a stronger humoral response than the BNT162b2 vaccine, according to a study published ...
Feb 16, 2022
0
4
A new study from MIT suggests that the dozens of mutations in the spike protein of the omicron variant help it to evade all four of the classes of antibodies that can target the SARS-CoV-2 virus that causes COVID-19.
Feb 1, 2022
0
182
An international team of scientists has determined the precise structural changes in the spike protein of the omicron variant. Their observations explain how the virus is able to evade antibodies against previous variants ...
Jan 25, 2022
0
153
